Increasing governmental regulation and enforcement by the U.S. Food and Drug Administration (FDA) has created new challenges and opportunities for innovation in the food, drug, cosmetics, and medical device industries. To offer strategic insights into the complexities of these challenges and prospects, Kilpatrick Townsend’s FDA Blog brings news and analysis on the latest legal developments so clients can effectively navigate this complex regulatory landscape throughout the lifecycle of their products — from development to marketing.
Kilpatrick Townsend’s FDA Regulatory Practice Group uses an integrated approach when providing effective and efficient legal services to FDA-regulated companies, including handling client matters before the Federal Trade Commission (FTC), Consumer Product Safety Commission (CSPC), and the National Advertising Division (NAD). Our multidisciplinary team provides comprehensive legal services, covering pharmaceuticals, over-the-counter drugs, and biologics; medical devices; foods and dietary supplements; cosmetics and personal care products; state and federal compliance; enforcement, imports, and inspections; congressional matters; and corporate due diligence in acquisitions, sales, or mergers of FDA-regulated entities or products.
More about our practice here : FDA Regulation
While we are pleased to have you contact us by telephone, surface mail, electronic mail, or by facsimile transmission, contacting Kilpatrick Townsend & Stockton LLP or any of its attorneys does not create an attorney-client relationship. The formation of an attorney-client relationship requires consideration of multiple factors, including possible conflicts of interest. An attorney-client relationship is formed only when both you and the Firm have agreed to proceed with a defined engagement.
DO NOT CONVEY TO US ANY INFORMATION YOU REGARD AS CONFIDENTIAL UNTIL A FORMAL CLIENT-ATTORNEY RELATIONSHIP HAS BEEN ESTABLISHED.
If you do convey information, you recognize that we may review and disclose the information, and you agree that even if you regard the information as highly confidential and even if it is transmitted in a good faith effort to retain us, such a review does not preclude us from representing another client directly adverse to you, even in a matter where that information could be used against you.